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Summary
Background: Studies of the characteristics, risk factors, prognostic factors,
and outcomes of diastolic heart failure (DHF) have yielded inconsistent ﬁnd-
ings. Moreover, few epidemiological studies of DHF have been performed in
Japan.
Methods and results: We studied patients with heart failure who were admitted
consecutively to Yokohama City University Hospital from 2000 through 2003. Heart
failure with a left ventricular ejection fraction (LVEF) of ≥50% was classiﬁed as
DHF (n = 67), and that with an LVEF of ≤35% was classiﬁed as systolic heart failure
(SHF; n = 72). Relative wall thickness (RWT) (0.61 vs. 0.34, p < 0.0001) and left ven-
tricular mass index (210.3 vs. 152.1, p < 0.0001) were greater in DHF than in SHF.
Age (odds ratio [OR] = 1.068, 95% CI = 1.020—1.119; p = 0.006) and RWT (OR = 17.945,
CI = 5.883—54.745; p < 0.0001) were positive risk factors for DHF. A history of myocar-
dial infarction was a negative risk factor for DHF (OR = 0.053, CI = 0.008—0.342;
p = 0.002). Left ventricular mass index was slightly but not signiﬁcantly related to
DHF (OR = 1.010, CI = 1.000—1.019; p = 0.053). Survival did not differ signiﬁcantly
between patients with DHF and those with SHF. Advancing age and a greater RWT
were positive risk factors for DHF.
∗ Corresponding author. Tel.: +81 45 787 2635; fax: +81 45 701 3738.
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of DHF and SHF are quite different. DHF is characterized by
of the left ventricle, whereas SHF is characterized by eccen-
d RWT were positive risk factors for DHF. Survival is similar in
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sion, and diabetes mellitus were each treated as
dummy variables (expressed as 1 if there was a his-
tory, 0 if otherwise). Potential prognostic factors forConclusion: LV geometry
concentric hypertrophy
tric hypertrophy. Age an
DHF and SHF.
© 2008 Japanese Colleg
reserved.
Introduction
Although 40—50% of patients with heart failure
have a preserved ejection fraction [1—3] and many
studies have focused on diastolic heart failure
(DHF), little is known about the characteristics, risk
factors, and prognostic factors of DHF. Whether sur-
vival is better in DHF than in systolic heart failure
(SHF) also remains unclear because previous stud-
ies have yielded inconsistent ﬁndings. Moreover,
few epidemiological studies of DHF have been per-
formed in Japan.
This study was designed to clarify the character-
istics, left ventricular (LV) geometry, risk factors,
prognostic factors, and outcomes of DHF as com-
pared with those of SHF in the Japanese population.
Methods
This was a retrospective cohort study. Patients with
heart failure who were consecutively admitted to
Yokohama City University Hospital from April 1,
2000 through March 31, 2003 were studied. Heart
failure was diagnosed according to the Framingham
study criteria [4]. For patients who were admitted
two or more times, only data from the initial admis-
sion were analyzed. On admission, each patient’s
medical history was reviewed. Echocardiographic
and laboratory test data obtained on admission
were used in this study. Left ventricular ejection
fraction (LVEF) was measured by echocardiography.
Heart failure with an LVEF of ≥50% was classiﬁed as
DHF, and that with an LVEF of ≤35% was classiﬁed
as SHF. Heart failure with an LVEF between 35%
and 50% was classiﬁed as intermediate type. To
clarify fundamental differences between DHF
and SHF, patients with intermediate type heart
failure were excluded from this study. Creatinine
clearance was estimated according to the formula
of Cockcroft and Gault as follows [5]: creatinine
clearance (ml/min) =K× (140− age) body weight
(kg)/(72× serum creatinine concentration), with
K equal to 1 for men and ×0.85 for women.
Left ventricular mass index (LVMI) and relative
wall thickness (RWT) were calculated using the
following equations, as recommended by the
European Association of Echocardiography and the
D
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sCardiology. Published by Elsevier Ireland Ltd. All rights
merican Society of Echocardiography [6,7]:LVMI
g/m2) = (0.8× {1.04× [(LVDd + IVSTd + PWTd)3 −
LVDd)3]} + 0.6)/body surface area, RWT=
2×PWTd)/LVDd, where LVDd indicates left
entricular diameter in diastole, IVSTd indicates
nterventricular septal wall thickness in diastole,
nd PWTd indicates left ventricular posterior wall
hickness in diastole. RWT permits categorization
f an increase in LV mass as either concentric
RWT >0.42) or eccentric (RWT ≤0.42), and of
ormal LV mass as either eccentric remodeling or
ormal geometry [7]. Smoking history was esti-
ated by the Brinkman index as follows: number of
igarettes smoked per day× the number of years of
moking. The alcohol intake score was calculated
y the following equation: 1 unit (about 20ml
thanol per day)× number of years of drinking.
utcomes after discharge were surveyed until
ay 6, 2007. The follow-up period ranged from
years 2 months to 7 years 2 months. Follow-up
nformation was obtained by reviewing the medical
ecords of our hospital. Information on patients
ho did not return to our outpatient clinic was
btained by telephone interviews with surviving
atients, family members, or patients’ personal
hysicians.
tatistical analysis
umerical data are expressed as means± SE. The
tatistical signiﬁcance of differences between DHF
nd SHF was evaluated by Student’s t-test and
hi-square test. Risk factors were evaluated by
ultivariate logistic regression analysis (dependent
ariable = 1 if DHF or 0 if SHF). In the model, sex was
reated as a dummy variable (male = 1, female = 0);
ge, body mass index (BMI), and LVMI were numeri-
al variables; RWT was treated as a dummy variable
expressed as 1 if RWT >0.42, 0 if otherwise);
nd histories of myocardial infarction, hyperten-HF were assessed with a Cox proportional-hazards
odel. Finally, we estimated overall survival by the
aplan—Meier method and tested for differences in
urvival between patients with DHF and those with
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aigure 1 Age distribution of patients hospitalized for
eart failure.
HF with the log-rank test. p Values of <0.05 were
onsidered to indicate statistical signiﬁcance.
esults
uring the study period, 335 patients with heart
ailure (211 men and 124 women) were admitted
o our hospital. Of the total, 180 patients (121 men
nd 59 women) were initially admitted and included
n this study. The type of heart failure was classi-
ed as DHF in 67 patients (37.2%), SHF in 72 (40.0%),
nd intermediate type in 41 (22.7%). Mean LVEF in
he DHF group, SHF group, and intermediate group
as 65.5%, 25.8%, and 41.8%, respectively. Advanc-
ng age was associated with a gradual increase in
he number of patients with heart failure until
he eighth decade (Figs. 1 and 2). At the time of
w
w
c
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Table 1 Clinical characteristics of diastolic heart failur
admission.
Variable DHF
Age (years) 70.8± 1.9
Sex (male/female)a 29/38
Brinkman index 687.0± 12
Alcohol intake score 40.4± 9.6
BMI 23.2± 0.4
NYHA (grade) 3.4± 0.1
Hypertension (%)a 44.7
Diabetes mellitus (%)a 31.3
Previous myocardial infarction (%)a 6.0
Valvular heart disease (%)a 14.9
Atrial ﬁbrillation (%)a 49.3
Heart rate (/min) 88± 3
Systolic blood pressure (mmHg) 151± 2
Diastolic blood pressure (mmHg) 81± 2
Plasma BNP (pg/ml) 732.9± 11
Serum creatinine (mg/dl) 2.28± 0.34
Creatinine clearance (ml/min) 45.2± 3.9
Values are expressed as mean± SE. Differences were analyzed by t
a Differences were analyzed by Chi-square test.ailure (DHF) or systolic heart failure (SHF). Black bars,
HF; white bars, SHF.
dmission, patients who had DHF were older and
ncluded a higher proportion of women as com-
ared with patients who had SHF (Table 1). As
or hemodynamic variables, systolic blood pres-
ure was higher in DHF than in SHF, heart rate
as lower in DHF than in SHF, and diastolic blood
ressure was similar in the two groups. Brinkman
ndex, alcohol intake score, and BMI were similar
n the two groups. The New York Heart Associ-
tion (NYHA) class was also similar in DHF (3.4)
nd SHF (3.5). A history of myocardial infarction
as signiﬁcantly less frequent in DHF than in SHF,
hereas a history of atrial ﬁbrillation was signiﬁ-
antly more frequent in DHF than in SHF. There was
o difference in history of hypertension, diabetes
e (DHF) and systolic heart failure (SHF) patients on
SHF p-value
62.1± 1.9 0.008
51/21 0.083
8.2 600.4± 132.0 0.548
43.5± 10.1 0.900
22.6± 0.5 0.380
3.5± 0.1 0.515
34.7 0.196
31.9 0.089
29.2 <0.0001
16.7 0.351
22.2 0.030
97± 3 0.037
132± 4 <0.0001
76± 3 0.187
7.0 1121.5± 109.4 0.020
2.20± 0.30 0.859
0.4± 4.7 0.414
test. BMI, body mass index; BNP, brain natriuretic peptide.
104 K. Uchino et al.
Table 2 Left ventricular geometry evaluated by echocardiography.
Parameter DHF SHF P-value
LVEF (%) 66.2± 1.3 25.7± 0.7 <0.0001
LVDd (mm) 48.3± 1.2 60.1± 1.0 <0.0001
IVSd (mm) 13.6± 0.3 9.7± 0.3 <0.0001
LVPWd (mm) 13.7± 0.3 10.0± 0.3 <0.0001
LVMI (mm/m2) 210.3± 9.9 152.1± 5.9 <0.0001
RWT 0.61± 0.04 0.34± 0.01 <0.0001
Concentric LV geometry (%) 85.1 16.2 <0.0001
Hypertrophic LV geometry (%) 57.8 86.7 0.2510
Values are expressed as mean± SE. Differences were analyzed by t test. DHF, diastolic heart failure; SHF, systolic heart failure;
LVEF, left ventricular ejection fraction; LVDd, left ventricular diastolic diameter; IVSd, interventiricular septal thickness in diastole;
LVPWd, left ventricular posterior wall thickness in diastole; LVMI, left ventricular mass index; RWT, relative wall thickness; LV, left
ventricular.
Table 3 Multivariate logistic regression analysis of risk factors for diastolic heart failure.
Odds ratio 95% conﬁdence interval p-value
Sex 0.523 0.158—1.734 0.289
Age 1.068 1.020—1.119 0.006
RWT 17.945 5.883—54.745 <0.0001
LVMI 1.010 1.000—1.019 0.053
Previous myocardial infarction 0.053 0.008—0.342 0.002
Diabetes mellitus 2.451 0.650—9.240 0.186
BMI,
8
o
c
b
a
r
t
T
a
m
nBMI 1.077
RWT, relative wall thickness; LVMI, left ventricular mass index;
mellitus, or valvular heart diseases between the
groups. Eighteen patients with dilated cardiomy-
opathy were included in the SHF group, whereas
only one patient had hypertrophic cardiomyopathy
in the DHF group. The plasma BNP level on admis-
sion was signiﬁcantly higher in the SHF group than
that in the DHF group. Serum creatinine concentra-
tion and creatinine clearance were similar in the
groups. As for echocardiographic data, LVDd was
signiﬁcantly greater in the SHF group than in the
DHF group, whereas IVSd thickness, PWd thickness,
LVMI, and RWT were signiﬁcantly greater in the DHF
group than in the SHF group (Table 2). Although both
DHF and SHF were associated with hypertrophic
LV geometry, concentric geometry was present in
a
d
m
t
Table 4 Cox proportional hazard analysis of mortality in p
Factor Hazard ratio
Age 1.205
Sex 0.539
NYHA grade 1.169
Creatinine clearance 0.995
BNP 1.000
LVMI 0.994
Atrial ﬁbrillation 1.653
RWT 1.409
NYHA, New York Heart Association; BNP, B-type natriuretic peptide;0.917—1.266 0.366
body mass index.
5.1% of the patients with DHF, as compared with
nly 16.2% of the patients with SHF. The medi-
ations being received at discharge did not differ
etween the groups. Multivariate logistic regression
nalysis revealed that age and RWT were positive
isk factors for DHF. A history of myocardial infarc-
ion was a negative risk factor for DHF (Table 3).
here was a strong, but insigniﬁcant trend toward
relation between LVMI and DHF. Diabetes and body
ass index were not risk factors for DHF. No prog-
ostic factor for DHF was found on multivariate
nalysis (Table 4). Kaplan—Meier analysis showed no
ifference in all-cause mortality or cardiovascular
ortality between the DHF and SHF groups during
he follow-up period (Figs. 3 and 4).
atients with diastolic heart failure.
95% conﬁdence interval p-value
0.765—1.897 0.4220
0.198—1.473 0.2280
0.571—2.394 0.6700
0.971—1.019 0.6670
1.000—1.001 0.3830
0.983—1.006 0.9940
0.490—5.573 0.4180
0.466—4.263 0.4180
LVMI, left ventricular mass index; RWT, relative wall thickness.
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Oigure 3 All-cause mortality plots of patients with dias-
olic heart failure (DHF) or systolic heart failure (SHF).
iscussion
n this study, we classiﬁed heart failure into three
roups according to criteria strictly deﬁning the
jection fraction: DHF, SHF, and intermediate type.
e then compared the DHF group with the SHF
roup to clarify the basic characteristics of DHF. To
ur knowledge, no previous study has deﬁned the
haracteristics of DHF and SHF as clearly as we have
one. Despite the use of stricter criteria to deﬁne
he type of heart failure, the prevalence of DHF
n our study was 37.2%, consistent with previous
ndings [1,8,9].
eft ventricular geometry of the heart
n DHF
ur study showed that LV geometry differed signiﬁ-
antly between DHF and SHF. LV wall thickness was
igniﬁcantly greater in DHF than in SHF. However,
V diastolic inner diameter in patients with DHF
emained within the normal range. In contrast, LV
iastolic inner diameter in patients with SHF was
igniﬁcantly larger than normal. When we applied
he LV geometrical classiﬁcation recommended by
he European Association of Echocardiography and
merican Society of Echocardiography [6,7], RWT
as 0.61 and LV geometry was classiﬁed as concen-
ric in DHF. In SHF, RWT was 0.34 and LV geometry
as classiﬁed as eccentric. On an individual basis,
V geometry was concentric in 85.1% of the patients
ith DHF and eccentric in 83.8% of the patients with
HF. Several sets of diagnostic criteria of hyper-
rophy using LVMI have been proposed [6,7,10].
egardless of which criteria were used, LVMI in
t
b
a
digure 4 Cardiovascular mortality plots of patients with
iastolic heart failure (DHF) or systolic heart failure
SHF).
oth DHF and SHF was always greater than normal,
ndicating LV hypertrophy. Our results do not sup-
ort the ﬁndings of a previous study [11], which
eported that RWT was 0.37 in DHF and 0.30 in
HF and classiﬁed LV geometry as non-concentric
n both DHF and SHF. The reasons for the differ-
nces in LV geometry between DHF and SHF are
nclear. However, experimental studies have sug-
ested that different turnover patterns of collagen,
atrix metalloproteinases (MMP), and endogenous
issue inhibitors of MMP underlie such differences
etween SHF and DHF [12—14]. Furthermore, ele-
ated serum levels of amino-terminal propeptide of
rocollagen type III and carboxy-terminal telopep-
ide of collagen type I have been reported in
HF, suggesting increased collagen synthesis [15].
n addition, structural differences in LV myocytes
etween SHF and DHF also appear to be involved.
uch differences include increased myocyte diam-
ter and a smaller decrease in myocyte volume in
HF as compared with SHF. An increased collagen
olume fraction in endomyocardial biopsy speci-
ens has also been reported in both types of heart
ailure [16].
isk factors for DHF
ur results conﬁrmed previous ﬁndings showing
hat patients with DHF are older and more likely to
e women [9,17]. The proportion of patients with
past history of diabetes mellitus or hypertension
id not differ between DHF and SHF. Multivariate
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logistic analysis revealed that age was a positive
risk factor for DHF, whereas sex, hypertension, and
diabetes mellitus were not. Our study also demon-
strated that LV geometry was characterized by
concentric hypertrophy in DHF and that a greater
RWT was a positive risk factor for DHF. Moreover,
LVMI was slightly but not signiﬁcantly related to
DHF. Interestingly, hypertension is often accom-
panied by LV concentricity, hypertrophy, or both.
Moreover, hypertension can cause three types of
LV remodeling: concentric hypertrophy, concen-
tric remodeling, or eccentric hypertrophy [18].
Our study showed that LV geometry in DHF was
characterized by concentric hypertrophy, possibly
resulting from hypertension. Most epidemiological
studies have suggested a somewhat higher preva-
lence of antecedent hypertension in DHF than in
SHF [19]. Hypertension has been reported to be a
common risk factor for DHF in Hong Kong [20]. In
our study, however, there was no statistically signif-
icant difference in history of hypertension between
DHF and SHF. Furthermore, hypertension was not
a risk factor for either DHF or SHF on multivari-
ate analysis. On the other hand, we found that
a history of myocardial infarction was a negative
risk factor for DHF, and few patients with DHF in
our series had a history of myocardial infarction.
Since myocardial infarction negatively affects sys-
tolic function, it is reasonable that a past history
of myocardial infarction was signiﬁcantly related
to SHF, but not DHF. The fact that hypertension
was not associated with either DHF or SHF in our
study suggests that hypertension contributes to
both types of heart failure [21,22]. This may be
the reason why hypertension was not found to be
a signiﬁcant independent risk factor for DHF in our
study.
In this study, atrial ﬁbrillation was not a signif-
icant risk factor for DHF, even though it was more
frequent in DHF than in SHF. The prevalence rate
of atrial ﬁbrillation has varied in previous stud-
ies. One study reported that the prevalence rate
of atrial ﬁbrillation was higher in DHF than in SHF
[9]; in contrast, other studies have reported no
difference in the prevalence rate of atrial ﬁbril-
lation between DHF and SHF [1,2,8]. In addition,
no study has shown that atrial ﬁbrillation is a risk
factor for DHF. These results appear to be reason-
able because atrial ﬁbrillation is often accompanied
by the development of symptomatic heart fail-
ure in previously asymptomatic patients with SHF.
However, because atrial ﬁbrillation mainly affects
diastolic function, the overall pumping ability of
the heart may also deteriorate. These factors might
explain why atrial ﬁbrillation was not found to be
a risk factor for DHF. A previous study reported
D
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hat DHF patients tend to be overweight [11]; how-
ver, BMI was not a risk factor for DHF in our
tudy.
utcomes
any studies have examined outcomes in patients
ith DHF. However, differences in outcomes
etween DHF and SHF remain controversial. Some
tudies reported that DHF is associated with lower
ortality than SHF, but with signiﬁcantly higher
ortality than that in the general population
2,23—25]. Other studies reported similar mortal-
ty in DHF and SHF [9,26—28]. Our study found no
ifference in all-cause or cardiovascular mortality
etween patients who were admitted for DHF or
HF. Our study also showed that mortality was very
igh among patients with heart failure who had a
istory of hospitalization.
In conclusion, LV geometry differed signiﬁcantly
etween DHF and SHF. DHF was characterized by
oncentric hypertrophy, whereas SHF was charac-
erized by eccentric hypertrophy. Advancing age
nd greater RWT were major positive risk factors
or DHF, and greater LVMI was slightly but not sig-
iﬁcantly related to DHF. A history of old myocardial
nfarction was a negative risk factor for DHF. These
isk factors may contribute to the pathogenesis of
HF. Mortality did not differ signiﬁcantly between
ospitalized patients with DHF and those with SHF.
tudy limitations
his study had two main limitations. First, it was
ot a population-based study, but was carried out
n a single institution with a limited number of
atients. Further population-based, large multicen-
er prospective studies are thus needed to clarify
f characteristics of patients with DHF in Japan.
econd, we lost 18.7% of the patients during follow-
p. Consequently, only the remaining 81.3% of the
atients could be followed-up during the study
eriod. However, there was no difference in the
ollow-up rate between the groups. Therefore, it
s unlikely that our conclusions were affected by
he rate of patient loss.isclosures
he authors have no conﬂicts of interest to disclose.
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